Skip to content

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

  • Home
  • About US
  • Bioinsight
  • Policy Hub
  • Deals Book
  • Privacy Policy
  • Contact US

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.

OTR Therapeutics

    • Home
    • OTR Therapeutics
Company Deals

OTR Therapeutics Series-A Raises $100M for Neurology Pipeline

Fineline Cube Dec 8, 2025

OTR Therapeutics Limited announced the successful completion of a USD 100 million Series A financing,...

Recent updates

  • Junshi Biosciences roconkibart psoriasis NMPA Acceptance
  • CSPC SYH2069 GLP-1/GIP Dual Agonist Wins FDA Nod for Obesity
  • Asieris APL-1401 Ulcerative-Colitis Phase 1b Data Positive
  • Balance Medical ePTFE Pericardial-Membrane Gets NMPA Nod, Ends Import Reliance
  • Shanghai Pharma X842 Deal Termination with Sinorda
Special Report 2025 Q1: U.S. Targets Chinese Pharma with 200% Tariffs—Will the Global Drug Market Collapse?

Category

  • Company
  • Deals
  • Digital
  • Drug
  • General/Other
  • Hospital
  • Legal / IP
  • Medical Device
  • Others
  • Policy / Regulatory
  • R&D

You Missed

Company Drug

Junshi Biosciences roconkibart psoriasis NMPA Acceptance

Company Drug

CSPC SYH2069 GLP-1/GIP Dual Agonist Wins FDA Nod for Obesity

Company Drug

Asieris APL-1401 Ulcerative-Colitis Phase 1b Data Positive

Company Medical Device

Balance Medical ePTFE Pericardial-Membrane Gets NMPA Nod, Ends Import Reliance

Insight, China's Pharmaceutical Industry

Fineline Insights, Pharma Clarity

Copyright © 2025 | Fineline Information & Technology | BlogData by Themeansar.